Assignee
AERPIO THERAPEUTICS INC
US·25 granted patents·27 pending applications·546 citations·filing 2012–2021
Top patents by PatentIndex Score
52 records- 0198US9949956B2Compounds, compositions, and methods for preventing metastasis of cancer cellsAERPIO THERAPEUTICS INC·Filed 2015·Granted Apr 24, 2018·21 cites·18 claims
- 0298USRE46592EHuman protein tyrosine phosphatase inhibitors and methods of useAERPIO THERAPEUTICS INC·Filed 2015·Granted Oct 31, 2017·25 cites·28 claims
- 0398US9795594B2Human protein tyrosine phosphatase inhibitors and methods of useAERPIO THERAPEUTICS INC·Filed 2016·Granted Oct 24, 2017·30 cites·13 claims
- 0498US9174950B2Compounds, compositions, and methods for preventing metastasis of cancer cellsAERPIO THERAPEUTICS INC·Filed 2014·Granted Nov 3, 2015·32 cites·20 claims
- 0597US10220048B2Compositions and methods for treating ocular diseasesAERPIO THERAPEUTICS INC·Filed 2016·Granted Mar 5, 2019·19 cites·13 claims
- 0697US9539245B2Combination of immunotherapies with activators of Tie-2AERPIO THERAPEUTICS INC·Filed 2015·Granted Jan 10, 2017·37 cites·40 claims
- 0797US9440963B2Compositions, formulations and methods for treating ocular diseasesAERPIO THERAPEUTICS INC·Filed 2014·Granted Sep 13, 2016·35 cites·60 claims
- 0897US9284285B2Human protein tyrosine phosphatase inhibitors and methods of useAERPIO THERAPEUTICS INC·Filed 2014·Granted Mar 15, 2016·27 cites·10 claims
- 0997US9126958B2Human protein tyrosine phosphatase inhibitors and methods of useAERPIO THERAPEUTICS INC·Filed 2014·Granted Sep 8, 2015·31 cites·17 claims
- 1097US9096555B2Methods for treating vascular leak syndromeAERPIO THERAPEUTICS INC·Filed 2012·Granted Aug 4, 2015·32 cites·2 claims
- 1197US8895563B2Human protein tyrosine phosphatase inhibitors and methods of useAERPIO THERAPEUTICS INC·Filed 2013·Granted Nov 25, 2014·35 cites·27 claims
- 1297US8883832B2Compounds, compositions, and methods for preventing metastasis of cancer cellsAERPIO THERAPEUTICS INC·Filed 2013·Granted Nov 11, 2014·38 cites·52 claims
- 1397US8846685B2Human protein tyrosine phosphatase inhibitors and methods of useAERPIO THERAPEUTICS INC·Filed 2012·Granted Sep 30, 2014·37 cites·4 claims
- 1496US8999325B2Treatment of ocular diseaseAERPIO THERAPEUTICS INC·Filed 2012·Granted Apr 7, 2015·36 cites·18 claims
- 1595US10329357B2Treatment of ocular diseaseAERPIO THERAPEUTICS INC·Filed 2017·Granted Jun 25, 2019·16 cites·11 claims
- 1695US10253094B2Antibodies that target human protein tyrosine phosphatase-beta (HPTP-beta) and methods of use thereof to treat ocular conditionsAERPIO THERAPEUTICS INC·Filed 2017·Granted Apr 9, 2019·13 cites·45 claims
- 1795US10150811B2Methods for treating vascular leak syndrome and cancerAERPIO THERAPEUTICS INC·Filed 2017·Granted Dec 11, 2018·15 cites·14 claims
- 1895US9926367B2Antibodies that bind human protein tyrosine phosphatase beta (HPTPbeta) and uses thereofAERPIO THERAPEUTICS INC·Filed 2017·Granted Mar 27, 2018·23 cites·11 claims
- 1993US9278930B2Methods for increasing the stabilization of hypoxia inducible factor-αAERPIO THERAPEUTICS INC·Filed 2015·Granted Mar 8, 2016·8 cites·13 claims
- 2093US8883774B2Methods for increasing the stabilization of hypoxia inducible factor-1 alphaAERPIO THERAPEUTICS INC·Filed 2013·Granted Nov 11, 2014·12 cites·12 claims
- 2192US8999971B2Methods for increasing the stabilization of hypoxia inducible factor-1 alphaAERPIO THERAPEUTICS INC·Filed 2014·Granted Apr 7, 2015·10 cites·20 claims
- 2290US9540326B2Prolyl hydroxylase inhibitorsAERPIO THERAPEUTICS INC·Filed 2015·Granted Jan 10, 2017·5 cites·12 claims
- 2388US9994560B2HPTP-β inhibitorsAERPIO THERAPEUTICS INC·Filed 2015·Granted Jun 12, 2018·8 cites·36 claims
- 2480US2022185778A1Prolyl hydroxylase inhibitorsAERPIO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2572US2018237429A1Compositions, formulations and methods for treating ocular diseasesAERPIO THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2672US2018237430A1Compositions, formulations and methods for treating ocular diseasesAERPIO THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2772US2018237431A1Compositions, formulations and methods for treating ocular diseasesAERPIO THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2870US10562854B2Prolyl hydroxylase inhibitorsAERPIO THERAPEUTICS INC·Filed 2018·Granted Feb 18, 2020·0 cites·13 claims
- 2970US2015050277A1Compositions and methods for treating ocular diseasesAERPIO THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 3069US2018022741A1Compositions, formulations and methods for treating ocular diseasesAERPIO THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3168US2019076405A1Compounds, compositions, and methods for preventing metasasis of cancer cellsAERPIO THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3268US2018251457A1Compositions, formulations and methods for treating ocular diseasesAERPIO THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3367US2016220540A1Compositions, formulations and methods for treating ocular diseasesAERPIO THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3466US2019231799A1Compositions and methods for treating ocular diseasesAERPIO THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3565US2017298019A1Prolyl hydroxylase inhibitorsAERPIO THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3665US2020010565A1Treatment of ocular diseaseAERPIO THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3764US9388135B2Process for preparing N-benzyl-3-hydroxy-4-substituted-pyridin-2-(1H)-onesAERPIO THERAPEUTICS INC·Filed 2015·Granted Jul 12, 2016·1 cites·29 claims
- 3863US2014066458A1Methods for treating vascular leak syndromeAERPIO THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 3963US2013331386A1Methods for treating vascular leak syndromeAERPIO THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 4063US2018092883A1Phosphatase inhibitors for treating ocular diseasesAERPIO THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 4163US2016220541A1Compositions, formulations and methods for treating ocular diseasesAERPIO THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4262US2019023773A1ANTIBODIES THAT BIND HUMAN PROTEIN TYROSINE PHOSPHATASE beta (HPTPbeta) AND USES THEREOFAERPIO THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4361US2014044707A1ANTIBODIES THAT BIND HUMAN PROTEIN TYROSINE PHOSPHATASE beta (HPTPbeta) AND USES TEHREOFAERPIO THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 4461US2018016245A1Methods for treating vascular leak syndromeAERPIO THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 4558US2014288134A1Compositions and methods for treating ocular edema, neovascularization and related diseasesAERPIO THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 4657US2013095065A1Methods for Treating Vascular Leak Syndrome and CancerAERPIO THERAPEUTICS INC·Filed 2012·Application pending·0 cites
- 4753US2015232575A1Treatment of ocular diseasesAERPIO THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 4853US2018037579A1Compositions and methods for treating ocular edema, neovascularization and related diseasesAERPIO THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 4952US2018353614A1VE-PTP Extracellular Domain Antibodies Delivered by a Gene Therapy VectorAERPIO THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 5047US2016082129A1VE-PTP Extracellular Domain Antibodies Delivered by a Gene Therapy VectorAERPIO THERAPEUTICS INC·Filed 2015·Application pending·0 cites
Showing the top 50 of 52 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when AERPIO THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →